| 摘要 |
FIELD: medicine.SUBSTANCE: invention refers to medicine, namely oncology and pulmonology, and concerns treating lung cancer. The therapeutic procedure is preceded by lymphocyte sampling from patient's blood by lymphocytapheresis to prepare a leukocytic mass. Then the leukocytic mass 20 ml is activated by ronkoleukine at 1000 units per 1 ml by incubation in a thermostat and double centrifugation. After the supernatant has been poured out, the residual cell mass is reduced to 20 ml by normal saline. That is followed by X-ray assissted immune chemoembolisation. Fresh activated leukocytic mass 20 ml is first introduced into the bronchial artery through a coaxial system with a microcatheter. The suspension of the chemopreparation and embolysate is administered.EFFECT: method provides the high anti-tumour effect which is characterised by tumour regression, prolonged recurrence-free interval, prolonged lifespan, as well as reduced polychemotherapy-induced secondary immunodeficiency, complex correction of cell and humoral factors of the immune homeostasis, reduced probability of developing bronchopulmonary pyoinflammatory complications.1 ex |
